Hepion Pharmaceuticals employing artificial intelligence to tackle NASH [BioTuesdays]
https://hepionpharma.com/wp-content/uploads/2020/11/BioTuesdays-November-2020.pdf
Amidst a global pandemic, two biotech companies offer innovative solutions [BioTuesdays]
https://biotuesdays.com/2020/03/31/amidst-a-global-pandemic-two-biotech-companies-offer-innovative-solutions/
Breakthrough lupus drug discovered in Edmonton passes final testing phase [Global News]
https://globalnews.ca/news/6273515/lupus-drug-edmonton-discovery/
Research institute launched out of U of A attracts $25 million in investments [Edmonton Journal]
https://edmontonjournal.com/business/local-business/research-institute-launched-out-of-u-of-a-attracts-25-million-in-investments
Hepion Pharmaceuticals’ CEO Robert Foster discusses CRV431’s potential in NASH [BioTuesdays]
https://www.biotuesdays.com/features/2019/7/30/hepion-pharmaceuticals-ceo-robert-foster-discusses-crv431s-potential-in-nash
